QCI Asset Management’s AstraZeneca AZN Stock Holding History

QCI Asset Management’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-509	Closed	-$45K	–	164
2020 Q1	$45K	Buy	509 +23	+5%	+$2.17K	﹤0.01%	241
2019 Q4	$48K	Hold	486	–	–	﹤0.01%	264
2019 Q3	$43K	Buy	486 +6	+1%	+$520	﹤0.01%	276
2019 Q2	$40K	Hold	480	–	–	﹤0.01%	302
2019 Q1	$39K	Sell	480 -34	-7%	-$2.68K	﹤0.01%	294
2018 Q4	$39K	Buy	514 +26	+5%	+$2.03K	﹤0.01%	285
2018 Q3	$39K	Hold	488	–	–	﹤0.01%	306
2018 Q2	$34K	Sell	488 -90	-16%	-$6.47K	﹤0.01%	289
2018 Q1	$40K	Hold	578	–	–	﹤0.01%	278
2017 Q4	$40K	Hold	578	–	–	﹤0.01%	277
2017 Q3	$39K	Sell	578 -640	-53%	-$40.4K	﹤0.01%	248
2017 Q2	$83K	Buy	1,218 +120	+11%	+$7.84K	0.01%	173
2017 Q1	$68K	Buy	1,098 +3	+0.3%	+$175	0.01%	185
2016 Q4	$60K	Hold	1,095	–	–	0.01%	185
2016 Q3	$72K	Buy	1,095 +10	+0.9%	+$654	0.01%	173
2016 Q2	$66K	Hold	1,085	–	–	0.01%	189
2016 Q1	$61K	Sell	1,085 -247	-19%	-$14.8K	0.01%	186
2015 Q4	$90K	Buy	1,332 +247	+23%	+$16.2K	0.01%	149
2015 Q3	$69K	Hold	1,085	–	–	0.01%	180
2015 Q2	$69K	Sell	1,085 -140	-11%	-$9.59K	0.01%	160
2015 Q1	$84K	Buy	1,225 +520	+74%	+$36.1K	0.01%	147
2014 Q4	$50K	Hold	705	–	–	0.01%	195
2014 Q3	$50K	Hold	705	–	–	0.01%	200
2014 Q2	$52K	Hold	705	–	–	0.01%	195
2014 Q1	$46K	Hold	705	–	–	0.01%	202
2013 Q4	$42K	Hold	705	–	–	0.01%	210
2013 Q3	$37K	Hold	705	–	–	0.01%	209
2013 Q2	$33K	Buy	+705	New	+$35.9K	0.01%	230

Other funds holding AZN

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $53.8B AUM 19.23% 1-Year Est. Return

QCI Asset Management's AZN Position: Q2 2020 in Review

QCI Asset Management sold out of AstraZeneca (AZN) in Q2 2020, closing a stake of 509 shares — an estimated $45K sold.

QCI Asset Management first reported a position in AZN in Q2 2013 and held it in 28 quarters. The position peaked at $90K in Q4 2015. 669 funds tracked by Wall St. Rank hold AZN as of Q2 2020.

QCI Asset Management reported no remaining AstraZeneca position as of Q2 2020 after selling out during the quarter.
QCI Asset Management sold 509 AstraZeneca shares in Q2 2020, an estimated $45K.
QCI Asset Management first reported a position in AstraZeneca in Q2 2013 and held it in 28 quarters.
QCI Asset Management's AstraZeneca position peaked at $90K in Q4 2015.
669 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2020.

Based on QCI Asset Management's 13F filing for Q2 2020, filed 31 Jul 2020.